Phase II Trial of Gemcitabine, Paclitaxel and Trastuzumab in Metastatic Breast Cancer: a Hoosier Oncology Group Trial

Abstracts/Posters/Presentations:

• Kathy D. Miller, Judy Sisk, Gary Gize, Sreenivasa Nattam, Rafat Ansari, Jake Vinson and George Sledge. Phase II study of gemcitabine, paclitaxel and trastuzumab in metastatic breast cancer; a Hoosier Oncology Group trial BRE99-1. Presented at the San Antonio Breast Cancer Symposium, December 11-14, 2002.

Manuscripts/Articles:

• KD, Sisk J, Gize G. Phase II Study of Gemcitabine, Paclitaxel and Trastuzumab in Metastatic Breast Cancer: A Hoosier Oncology Group Study BRE99-1. Breast Cancer Res Treat 2002;76(suppl 1):S113.